Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Kaleido Biosciences, Inc. | kldo-ex321_11.htm |
| EX-31.2 - EX-31.2 - Kaleido Biosciences, Inc. | kldo-ex312_9.htm |
| EX-21.1 - EX-21.1 - Kaleido Biosciences, Inc. | kldo-ex211_8.htm |
| EX-32.2 - EX-32.2 - Kaleido Biosciences, Inc. | kldo-ex322_6.htm |
| EX-4.3 - EX-4.3 - Kaleido Biosciences, Inc. | kldo-ex43_12.htm |
| EX-31.1 - EX-31.1 - Kaleido Biosciences, Inc. | kldo-ex311_10.htm |
| 10-K - 10-K - Kaleido Biosciences, Inc. | kldo-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-240323 and 333-236804 each on Form S-3 and Registration Statement Nos. 333-238123 and 333-230167 each on Form S-8 of our report dated March 3, 2021, relating to the financial statements of Kaleido Biosciences, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
March 3, 2021